TRIPAWDS: Home to 22971 Members and 2152 Blogs.
HOME » NEWS » BLOGS » FORUMS » CHAT » YOUR PRIVACY » RANDOM BLOG

Caring for a Three Legged Dog or Cat

Tripawds is your home to learn how to care for a three legged dog or cat, with answers about dog leg amputation, and cat amputation recovery from many years of member experiences.

JUMP TO FORUMS

Join The Tripawds Community

Learn how to help three legged dogs and cats in the forums below. Browse and search as a guest or register for free and get full member benefits:

Instant post approval.

Private messages to members.

Subscribe to favorite topics.

Live Chat and much more!

Please consider registering
Guest
Search
Forum Scope


Match



Forum Options



Minimum search word length is 3 characters - maximum search word length is 84 characters
Register Lost password?
sp_Feed sp_PrintTopic sp_TopicIcon-c
University of Missouri Clinical Trial: Canine Cachexia Study
sp_NewTopic Add Topic
On The Road


Member Since:
24 September 2009
sp_UserOfflineSmall Offline
1
18 April 2017 - 12:12 pm
sp_Permalink sp_Print sp_QuotePost

Mizzou seeks canine cancer patients for clinical trials

The University of Missouri’s Veterinary Health Center is seeking cancer-stricken canines to test a drug researchers hope will let dogs — and maybe someday humans — live longer.

The university is running clinical trials in partnership with Tensive Controls Inc. on a medication for cachexia, a wasting syndrome that causes about one-third of cancer deaths.

Cachexia occurs with advanced cancers, causes loss of appetite and can lead to multiorgan failure.

Read more here: http://www.kans.....rylink=cpy

For a direct link to the Mizzou website page about the trial, see Current Clinical Trials. Here's a description of the study:

Canine Cachexia Clinical Trial

The true prevalence of cachexia in canine patients has not been determined, due in part to euthanasia when a pet’s quality of life declines and weight loss ensues. The objectives for this study are to determine toxicity, including cardiovascular effects of the final drug candidate of MC4 peptide receptor antagonist and to determine preliminary efficacy of MC4 peptide receptor antagonist in dogs with cachexia.

Criteria:

  • History of 5% or greater with loss within past three months
  • Radiation and chemotherapy allowed at clinician discretion
  • Washout of 2 days required for appetite stimulants.
  • CBC, chemistry panel, UA, and abdominal ultrasound within 14 days of enrollment
  • Corticosteriod use allowed if > 14 days prior to enrollment

Tripawds Founders Jim and Rene
tripawds.com | tripawds.org | bemoredog.net | triday.pet

Forum Timezone: America/Denver
Most Users Ever Online: 946
Currently Online: Edward_1
Guest(s) 216
Currently Browsing this Page:
1 Guest(s)
Member Stats:
Guest Posters: 1268
Members: 17733
Moderators: 6
Admins: 3
Forum Stats:
Groups: 4
Forums: 24
Topics: 18610
Posts: 256803
Administrators: admin, jerry, Tripawds
Tripawds is brought to you by Tripawds.
HOME » NEWS » BLOGS » FORUMS » CHAT » YOUR PRIVACY » RANDOM BLOG